Twist Bioscience Corp vs Western Alliance Bancorporation — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while Western Alliance Bancorporation trades at $79.8 (market cap $8.84B). The key difference: Western Alliance Bancorporation is the larger of the two by market cap, and Western Alliance Bancorporation pays a 2.07% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TWST | WAL | |
|---|---|---|
Market Cap | $5.45B | $8.84B |
Sector | Health | Financials |
52-Week High | $102.88 | $96.08 |
52-Week Low | $24.16 | $66.70 |
Enterprise Value | $5.37B | — |
Dividend Yield | — | 2.07% |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →